NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Mangalam Drugs And Organics Limited (NSE: MANGALAM)

 
MANGALAM Technical Analysis
3
As on 12th Apr 2024 MANGALAM SHARE Price closed @ 102.70 and we RECOMMEND Sell for LONG-TERM with Stoploss of 105.22 & Sell for SHORT-TERM with Stoploss of 108.65 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

MANGALAMSHARE Price

Open 103.70 Change Price %
High 104.85 1 Day 1.30 1.28
Low 101.45 1 Week -1.60 -1.53
Close 102.70 1 Month -1.25 -1.20
Volume 36511 1 Year -12.25 -10.66
52 Week High 162.55 | 52 Week Low 96.75
 
NSE INDIA Most Active Stocks
IDEA 12.95 0.00%
YESBANK 24.25 -0.82%
SAIL 155.35 1.50%
RPOWER 27.35 -3.53%
BEL 233.50 2.08%
ZOMATO 192.10 -2.44%
TATASTEEL 163.50 -0.94%
SUNDARAM 3.45 4.55%
NHPC 92.25 -0.65%
RELINFRA 197.75 -13.12%
 
NSE INDIA Top Gainers Stocks
AARVI 161.10 20.00%
NDL 43.65 18.45%
RAMCOSYS 396.35 16.27%
DPABHUSHAN 1122.10 11.60%
YUKEN 925.90 11.51%
GKWLIMITED 2301.55 10.00%
PURVA 324.05 10.00%
ASHIANA 335.00 9.91%
SBC 25.65 9.85%
SBC 25.65 9.85%
 
NSE INDIA Top Losers Stocks
RELINFRA 197.75 -13.12%
ORICONENT 41.45 -11.05%
EXCEL 0.50 -9.09%
ORTINLAB 19.95 -8.28%
KEYFINSERV 192.30 -7.84%
EMKAY 163.40 -7.63%
PSPPROJECT 673.40 -7.26%
TGBHOTELS 15.75 -6.53%
SUPREMEENG 0.75 -6.25%
MANGCHEFER 117.10 -6.24%
 
 
MANGALAM
Daily Charts
MANGALAM
Intraday Charts
Whats New @
Bazaartrend
MANGALAM
Free Analysis
 
MANGALAM Important Levels Intraday
RESISTANCE109.25
RESISTANCE107.15
RESISTANCE105.85
RESISTANCE104.55
SUPPORT100.85
SUPPORT99.55
SUPPORT98.25
SUPPORT96.15
 
MANGALAM Target April 2024
4th UP Target185.51
3rd UP Target165.24
2nd UP Target152.71
1st UP Target140.18
1st DOWN Target104.42
2nd DOWN Target91.89
3rd DOWN Target79.36
4th DOWN Target59.09
 
MANGALAM Weekly Target
4th UP Target131.66
3rd UP Target122.89
2nd UP Target117.46
1st UP Target112.04
1st DOWN Target96.56
2nd DOWN Target91.14
3rd DOWN Target85.71
4th DOWN Target76.94
 
MANGALAM Target2024
4th UP Target229.48
3rd UP Target187.36
2nd UP Target161.33
1st UP Target135.29
1st DOWN Target61.01
2nd DOWN Target34.97
3rd DOWN Target8.94
4th DOWN Target-33.18
 
 
MANGALAM Synopsis Technicals View
50 Day EMA Close is Above EMA 50 (Short Term)
Bullish
100 Day EMA Close is Above EMA 100 (Mid Term) Bullish
200 Day EMA Close is Above EMA 200 (Long Term) Bullish
MACD (12 26 9) MACD Line is Less Then SIGNAL Line Bearish
RSI (14) RSI is Below 30 Over Sold
MFI (14) MFI is Below 20 Over Sold
CCI (20) CCI is Below -100 Over Sold
WILLIAM %R (14) William %R is Below -80 Over Sold
ADX (14) ADX is Above 20 & +DI is Below -DI Down Trend
PSAR Stoploss For Long Buy 27.03
10 Day Avg Volume Traded -35.67 % Less then 10 Day Average Volume
 
MANGALAM Other Details
Segment EQ
Market Capital 2224694016.00
Sector Healthcare
Industry Drug Manufacturers-Specialty & Generic
Offical website >
 
MANGALAM Address
MANGALAM
 
MANGALAM Latest News
 
Your Comments and Response on Mangalam Drugs And Organics Limited
 
MANGALAM Business Profile
Mangalam Drugs & Organics Limited manufactures and sells drugs, medicines, and allied products in India and internationally. It offers a range of active pharmaceutical ingredients, intermediates, and specialty chemicals, as well as impurities for use in anti-malarial, analgesic/anti-inflammatory, anti-hypertensive, and anti-retroviral applications. The company was incorporated in 1972 and is based in Mumbai, India. Address: Rupam Building, Mumbai, India, 400001
 
2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service